The FDA has approved Remicade(R) (infliximab) for long-term remission-level control of debilitating symptoms of Crohn’s disease (CD).

על פי דיווח של חברת OGS , דחה ה- FDA את בקשת החברה לתכשיר החדש, ,Vevesca , לטיפול

NEW YORK (Reuters Health) Jul 05 –  In the treatment of type 2 diabetes with pioglitazone (Actos;

NEW YORK (Reuters Health) Jul 05 –  In patients with coronary artery disease (CAD), treatment with atorvastatin

MONTREAL, QC — July 5, 2002 —  In the largest clinical study ever conducted with a cholesterol-modifying

Both fluticasone and budesonide therapies are effective in treating seasonal allergic rhinitis but when compared, fluticasone results

– Intravenous immunoglobulin (IVIg) therapy is a safe and effective option for treating patients with nonresponsive and

Oral ketoprofen in a dual-release formulation is about as effective as zolmitriptan in controlling acute migraine, according

— Women should discuss the role of preventive therapy for breast cancer with their physicians, according to

June 27, 2002 — Orlistat (Xenical) is beneficial for obese type 2 diabetic patients, according to results